| Financial Year |
March 31 2023 |
| Monetary Funds |
337,583,941.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
39,925,918.19 |
| Advances to Suppliers |
15,804,631.00 |
| Other Receivables |
1,205,707.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
519,739,149.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
93,929,858.71 |
| Total Current Assets |
1,136,604,041.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,545,667.56 |
| Investment Properties |
-- |
| Fixed Assetes |
6,435,297,004.91 |
| Under-construction Projects |
73,471,611.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
570,444,116.81 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
59,842,359.75 |
| Deferred Income Tax Assets |
262,786,263.72 |
| Other Non-Current Assets |
219,772,000.00 |
| Sub-Total of Non-Current Assets |
7,631,159,023.84 |
| Total Assets |
8,767,763,065.72 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
422,600,000.00 |
| Accounts Payable |
589,467,736.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
61,567,609.04 |
| Taxes Payable |
558,969,727.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
61,229,176.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
34,158,581.31 |
| Other Current Liabilities |
12,475,018.06 |
| Sub-Total of Current Liabilities |
1,836,429,525.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
35,785,228.95 |
| Special Payable |
-- |
| Estimatied Liabilities |
112,265,729.61 |
| Deferred Income Tax Liabilities |
95,293,684.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
438,550,724.80 |
| Total Liabilities |
2,274,980,250.49 |
| Paid-In Capital(Or Share Stock) |
3,507,401,812.00 |
| Capital Surplus |
1,313,564,228.98 |
| Surplus Reserve |
162,846,433.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,461,817,474.01 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,492,782,815.23 |
| Owner's Equity（Stockholder's Equity） |
6,492,782,815.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,767,763,065.72 |
